Thomas Wilder

Thomas Wilder

Directeur/Membre du Conseil chez PENUMBRA, INC.

Fortune : 2 M $ au 31/08/2026

62 ans
Health Technology
Consumer Services
Finance

Profil

Mr. Thomas C.
Wilder
is a Chief Executive Officer at VS3 Medical, Inc., an Advisor at Vensana Capital Management LLC, an Independent Director at Penumbra, Inc. and an Independent Director at Neuros Medical, Inc. He is on the Board of Directors at Penumbra, Inc. and Neuros Medical, Inc. Mr. Wilder was previously employed as a Senior Advisor by CBC Group (Singapore) Pte.
Ltd., an Independent Director by Endologix LLC, a President, Chief Executive Officer & Director by Sequent Medical, Inc., a President & Chief Executive Officer by PhotoThera, Inc., a President & Chief Executive Officer by Micro Therapeutics, Inc., a VP & GM-Endovascular Stent Grafts Division by Medtronic, Inc., a President by ev3, Inc., and a Vice President-Finance & Information Technology by Medtronic Vascular, Inc. He also served on the board at Benvenue Medical, Inc. He received his undergraduate degree from Stanford University and an MBA from Kellogg School of Management.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 4 653 ( 0,01 % ) 2 M $ 31/08/2026

Postes actifs de Thomas Wilder

SociétésPosteDébut
PENUMBRA, INC. Directeur/Membre du Conseil 13/01/2017
Directeur/Membre du Conseil 28/08/2017
Consultant / Advisor 01/10/2019
Directeur Général 01/06/2024

Anciens postes connus de Thomas Wilder

SociétésPosteFin
ENDOLOGIX, INC. Directeur/Membre du Conseil 01/10/2020
Directeur/Membre du Conseil 01/04/2017
Directeur Général 01/07/2016
Directeur Général 30/04/2009
President -
Voir l'expérience en détail de Thomas Wilder

Formation de Thomas Wilder

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

86

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Finance

Health Services

  1. Bourse
  2. Insiders
  3. Thomas Wilder
🔇